Valuation: Original Source Entertainment Inc

Market Cap 12.11M 10.64M 10.03M 9.16M 17.12M 1.16B 17.27M 120M 46.56M 592M 45.47M 44.48M 1.92B P/E 2026 *
-1.81x
P/E 2027 * -2.1x
Enterprise Value 12.11M 10.64M 10.03M 9.16M 17.12M 1.16B 17.27M 120M 46.56M 592M 45.47M 44.48M 1.92B EV / Sales 2026 *
1.27x
EV / Sales 2027 * 0.91x
Free-Float
74.41%
Yield 2026 *
-
Yield 2027 * -
09-17 Neuroone Medical Technologies Corporation Expands U.S. Commercialization of Fda-Cleared Onerf Trigeminal Nerve Ablation System with New Southern California Distribution Agreement CI
08-27 NeuroOne Medical Technologies Corporation Reports Successful Large-Animal Procedures Using Next-Generation StereoCED Platform CI
08-13 NeuroOne Medical Technologies Corporation, Q3 2026 Earnings Call, Aug 13, 2026
08-13 NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 CI
08-13 Neuroone Medical Technologies Corporation Provides Revenue Guidance for the Fiscal Year 2026 CI
07-28 NeuroOne Medical Technologies Highlights Potential Paradigm Shift for Patients Treated with the Onerf Brain Ablation System CI
07-16 NeuroOne Medical Technologies Corporation and Mayo Clinic Expand Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial CI
06-29 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell 3000E Growth Benchmark CI
06-29 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell 3000E Index CI
06-29 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell Microcap Index CI
06-28 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell Microcap Growth Benchmark Index CI
05-22 NeuroOne Medical Technologies Corporation Reaffirms Product Revenue Guidance for the Fiscal Year 2026 CI
05-22 Neuroone Medical Technologies Corporation Announces Restatement of Financial Results for the Quarter Ended March 31, 2026 CI
Manager TitleAgeSince
Corporate Officer/Principal 59 2019-01-31
Chief Executive Officer 61 2017-07-19
Director of Finance/CFO 55 2026-06-30
Director TitleAgeSince
Chairman 70 2017-08-03
Director/Board Member 65 2017-08-03
Director/Board Member 61 2017-07-19
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.2M
+4.86%+9.45%+26.33%-16.55% 18.05B
-5.20%-1.65%-40.51%+23.38% 1.95B
-1.54%+1.16%-32.35%+22.85% 881M
+0.11%0.00%+52.02%-1.91% 778M
+3.38%-0.74%-61.04%-85.08% 709M
-0.69%+8.73%-29.95%-46.60% 691M
+1.77%+2.48%-36.80%-51.24% 579M
+5.30%+16.13%+52.58%+90.73% 452M
-0.95%+1.96%-6.83%+0.85% 404M
Average +0.70%+3.11%-8.51%-7.06% 2.72B
Weighted average by Cap. +3.32%+3.65%+14.04%-12.87%

Financials

2026 *2027 *
Net sales 9.54M 8.38M 7.89M 7.21M 13.48M 915M 13.6M 94.53M 36.66M 466M 35.8M 35.02M 1.51B 13.33M 11.71M 11.03M 10.08M 18.84M 1.28B 19M 132M 51.24M 651M 50.04M 48.95M 2.12B
Net income -7.8M -6.86M -6.46M -5.9M -11.03M -749M -11.13M -77.37M -30M -381M -29.3M -28.66M -1.24B -6.76M -5.94M -5.6M -5.11M -9.56M -648M -9.64M -67M -25.99M -330M -25.38M -24.82M -1.07B
Net Debt - -
Logo Original Source Entertainment Inc
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-